bevacizumab

B3E1V4A1C3I1Z10U1M3A1B3
US/ˌbɛv.əˈsɪz.ʊˌmæb/

noun

An anticancer drug that is a genetically engineered monoclonal antibody administered intravenously to slow or inhibit tumor growth especially in some metastatic forms of cancer (such as colorectal cancer). It acts by binding to and inhibiting the activity of vascular endothelial growth factor, a protein that promotes the growth of new blood vessels which supply a spreading tumor. It is marketed under the trademark Avastin.

UncommonScrabble 31
Ask AI about this wordChatGPTClaudePerplexityGoogle AIGrok

Meanings

nounbevacizumab (uncountable)
  1. uncountablemedicineAn anticancer drug that is a genetically engineered monoclonal antibody administered intravenously to slow or inhibit tumor growth especially in some metastatic forms of cancer (such as colorectal cancer). It acts by binding to and inhibiting the activity of vascular endothelial growth factor, a protein that promotes the growth of new blood vessels which supply a spreading tumor. It is marketed under the trademark Avastin.

Origin

From beva- (of unknown origin) + -ci- (“cardiovascular”) + -zumab (“humanized monoclonal antibody”).

Full word history & related roots →
Cite this entry
APA

bevacizumab. (n.d.). In WatkinsX Dictionary. Retrieved November 4, 2026, from https://dictionary.watkinsx.com/word/bevacizumab

MLA

“bevacizumab.” WatkinsX Dictionary, https://dictionary.watkinsx.com/word/bevacizumab. Accessed November 4, 2026.

Chicago

WatkinsX Dictionary, s.v. “bevacizumab,” accessed November 4, 2026, https://dictionary.watkinsx.com/word/bevacizumab.

Source: bevacizumab on Wiktionary, CC BY-SA 4.0.